Worldwide Incidence and Prevalence of Neuromyelitis OpticaViktoria Papp, Zsolt Illés, Melinda Magyari et al.|Neurology|2020Cited by 303
Initial high-efficacy disease-modifying therapy in multiple sclerosisMathias Due Buron, Melinda Magyari, Viktoria Papp et al.|Neurology|2020Cited by 160
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in DenmarkViktoria Papp, Thor Petersen, Zsolt Illés et al.|Neurology|2018Cited by 104
A population‐based epidemiological study of neuromyelitis optica spectrum disorder in HungaryViktoria Papp, Zsolt Illés, Anna Iljicsov et al.|European Journal of Neurology|2019Cited by 41
Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort studyLuigi Pontieri, Melinda Magyari, Morten Blinkenberg et al.|European Journal of Neurology|2021Cited by 29